Laboratory for Molecular Diagnostics
Center for Nephrology and Metabolic Disorders

Age-related macula degeneration 01

Age-related macula degeneration is a hereditary immunological disorder of progressive visual impairment that is associated with many different genes.

Systematic

Macular degeneration
Age-related macula degeneration 01
APOE
ARMS2
C2
C3
CFH
CFHR1
CFHR3
KCNT2
Early-onset macula degeneration

References:

1.

Maller J et al. (2006) Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration.

[^]
2.

Bergeron-Sawitzke J et al. (2009) Multilocus analysis of age-related macular degeneration.

[^]
3.

Lambooij AC et al. (2003) Insulin-like growth factor-I and its receptor in neovascular age-related macular degeneration.

[^]
4.

Seddon JM et al. (2005) Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers.

[^]
5.

Doyle SL et al. (2012) NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components.

[^]
6.

Tarallo V et al. (2012) DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88.

[^]
7.

Majewski J et al. (2003) Age-related macular degeneration--a genome scan in extended families.

[^]
8.

Seddon JM et al. (2003) A genomewide scan for age-related macular degeneration provides evidence for linkage to several chromosomal regions.

[^]
9.

Weeks DE et al. (2004) Age-related maculopathy: a genomewide scan with continued evidence of susceptibility loci within the 1q31, 10q26, and 17q25 regions.

[^]
10.

Jakobsdottir J et al. (2005) Susceptibility genes for age-related maculopathy on chromosome 10q26.

[^]
11.

Bhattacharjee A et al. (2003) Slick (Slo2.1), a rapidly-gating sodium-activated potassium channel inhibited by ATP.

[^]
12.

Kenealy SJ et al. (2004) Linkage analysis for age-related macular degeneration supports a gene on chromosome 10q26.

[^]
13.

Fisher SA et al. (2005) Meta-analysis of genome scans of age-related macular degeneration.

[^]
14.

Rivera A et al. (2005) Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk.

[^]
15.

Schmidt S et al. (2006) Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration.

[^]
16.

Conley YP et al. (2006) CFH, ELOVL4, PLEKHA1 and LOC387715 genes and susceptibility to age-related maculopathy: AREDS and CHS cohorts and meta-analyses.

[^]
17.

Dewan A et al. (2006) HTRA1 promoter polymorphism in wet age-related macular degeneration.

[^]
18.

Schaumberg DA et al. (2007) A prospective study of 2 major age-related macular degeneration susceptibility alleles and interactions with modifiable risk factors.

[^]
19.

Kanda A et al. (2007) A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration.

[^]
20.

Fritsche LG et al. (2008) Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA.

[^]
21.

Francis PJ et al. (2008) Rhesus monkeys and humans share common susceptibility genes for age-related macular disease.

[^]
22.

Ho L et al. (2011) Reducing the genetic risk of age-related macular degeneration with dietary antioxidants, zinc, and ω-3 fatty acids: the Rotterdam study.

[^]
23.

Fritsche LG et al. (2013) Seven new loci associated with age-related macular degeneration.

[^]
24.

Malek G et al. (2005) Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration.

[^]
25.

None (1966) Dystrophy of the macula.

[^]
26.

Heiba IM et al. (1994) Sibling correlations and segregation analysis of age-related maculopathy: the Beaver Dam Eye Study.

[^]
27.

Seddon JM et al. (1997) Familial aggregation of age-related maculopathy.

[^]
28.

Allikmets R et al. (1997) Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration.

[^]
29.

Klein ML et al. (1998) Age-related macular degeneration. Clinical features in a large family and linkage to chromosome 1q.

[^]
30.

Smith RS et al. (2000) The bst locus on mouse chromosome 16 is associated with age-related subretinal neovascularization.

[^]
31.

Weeks DE et al. (2000) A full genome scan for age-related maculopathy.

[^]
32.

Beatty S et al. () The role of oxidative stress in the pathogenesis of age-related macular degeneration.

[^]
33.

Yannuzzi LA et al. (2001) Retinal angiomatous proliferation in age-related macular degeneration.

[^]
34.

Weeks DE et al. (2001) Age-related maculopathy: an expanded genome-wide scan with evidence of susceptibility loci within the 1q31 and 17q25 regions.

[^]
35.

Dithmar S et al. (2001) Murine high-fat diet and laser photochemical model of basal deposits in Bruch membrane.

[^]
36.

Krzystolik MG et al. (2002) Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment.

[^]
37.

None (2002) Retinal angiomatous proliferation in age-related macular degeneration.

[^]
38.

Crabb JW et al. (2002) Drusen proteome analysis: an approach to the etiology of age-related macular degeneration.

[^]
39.

None (2002) New insights and new approaches toward the study of age-related macular degeneration.

[^]
40.

Malek G et al. (2003) Apolipoprotein B in cholesterol-containing drusen and basal deposits of human eyes with age-related maculopathy.

[^]
41.

Cousins SW et al. (2003) Female gender, estrogen loss, and Sub-RPE deposit formation in aged mice.

[^]
42.

Jonasson F et al. (2003) The prevalence of age-related maculopathy in iceland: Reykjavik eye study.

[^]
43.

Borrillo JL et al. (2003) Surgical ablation of retinal angiomatous proliferation.

[^]
44.

Phipps JA et al. (2003) Loss of cone function in age-related maculopathy.

[^]
45.

Klein R et al. (2003) Association of emphysema, gout, and inflammatory markers with long-term incidence of age-related maculopathy.

[^]
46.

Danciger M et al. (2003) A strong and highly significant QTL on chromosome 6 that protects the mouse from age-related retinal degeneration.

[^]
47.

Hahn P et al. (2003) Maculas affected by age-related macular degeneration contain increased chelatable iron in the retinal pigment epithelium and Bruch's membrane.

[^]
48.

Heckenlively JR et al. (2003) Mouse model of subretinal neovascularization with choroidal anastomosis.

[^]
49.

Schultz DW et al. (2003) Analysis of the ARMD1 locus: evidence that a mutation in HEMICENTIN-1 is associated with age-related macular degeneration in a large family.

[^]
50.

Espinosa-Heidmann DG et al. (2004) Basal laminar deposit formation in APO B100 transgenic mice: complex interactions between dietary fat, blue light, and vitamin E.

[^]
51.

Iyengar SK et al. (2004) Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration.

[^]
52.

Axer-Siegel R et al. (2004) Association of neovascular age-related macular degeneration and hyperhomocysteinemia.

[^]
53.

Scholl HP et al. (2004) What is lost by digitizing stereoscopic fundus color slides for macular grading in age-related maculopathy and degeneration?

[^]
54.

Grisanti S et al. (2004) Expression of endoglin in choroidal neovascularization.

[^]
55.

Jonas JB et al. (2004) Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration.

[^]
56.

Klein R et al. (2004) The epidemiology of age-related macular degeneration.

[^]
57.

None (2004) Current concepts in the pathogenesis of age-related macular degeneration.

[^]
58.

Jonasson F et al. (2005) 5-year incidence of age-related maculopathy in the Reykjavik Eye Study.

[^]
59.

Ethen CM et al. (2005) Declines in arrestin and rhodopsin in the macula with progression of age-related macular degeneration.

[^]
60.

Goverdhan SV et al. (2005) Association of HLA class I and class II polymorphisms with age-related macular degeneration.

[^]
61.

Postel EA et al. (2005) Comparing age-related macular degeneration phenotype in probands from singleton and multiplex families.

[^]
62.

Dunaief JL et al. (2005) Macular degeneration in a patient with aceruloplasminemia, a disease associated with retinal iron overload.

[^]
63.

Schultz DW et al. (2005) HEMICENTIN-1 (FIBULIN-6) and the 1q31 AMD locus in the context of complex disease: review and perspective.

[^]
64.

Thornton J et al. (2005) Smoking and age-related macular degeneration: a review of association.

[^]
65.

Chowers I et al. (2006) The iron carrier transferrin is upregulated in retinas from patients with age-related macular degeneration.

[^]
66.

Imamura Y et al. (2006) Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: a model of age-related macular degeneration.

[^]
67.

None (2006) Age-related macular degeneration.

[^]
68.

Nolan JM et al. (2007) Risk factors for age-related maculopathy are associated with a relative lack of macular pigment.

[^]
69.

Tamer C et al. (2007) Serum dehydroepiandrosterone sulphate level in age-related macular degeneration.

[^]
70.

Fisher SA et al. (2007) Case-control genetic association study of fibulin-6 (FBLN6 or HMCN1) variants in age-related macular degeneration (AMD).

[^]
71.

Tan JS et al. (2007) Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study.

[^]
72.

Decanini A et al. (2007) Changes in select redox proteins of the retinal pigment epithelium in age-related macular degeneration.

[^]
73.

Kim DH et al. (2007) Strategies for silencing human disease using RNA interference.

[^]
74.

Gupta SK et al. (2007) Prevalence of early and late age-related macular degeneration in a rural population in northern India: the INDEYE feasibility study.

[^]
75.

Boekhoorn SS et al. (2007) Estrogen receptor alpha gene polymorphisms associated with incident aging macula disorder.

[^]
76.

Chakravarthy U et al. (2007) Cigarette smoking and age-related macular degeneration in the EUREYE Study.

[^]
77.

Schaumberg DA et al. (2007) High-sensitivity C-reactive protein, other markers of inflammation, and the incidence of macular degeneration in women.

[^]
78.

Tan JS et al. (2007) Statins and the long-term risk of incident age-related macular degeneration: the Blue Mountains Eye Study.

[^]
79.

Bhosale P et al. (2007) Identification of 3-methoxyzeaxanthin as a novel age-related carotenoid metabolite in the human macula.

[^]
80.

Kamei M et al. (2007) Scavenger receptors for oxidized lipoprotein in age-related macular degeneration.

[^]
81.

Sivaprasad S et al. (2007) Estimation of systemic complement C3 activity in age-related macular degeneration.

[^]
82.

De S et al. (2007) Human retinal pigment epithelium cell changes and expression of alphaB-crystallin: a biomarker for retinal pigment epithelium cell change in age-related macular degeneration.

[^]
83.

Maruko I et al. (2007) Clinical characteristics of exudative age-related macular degeneration in Japanese patients.

[^]
84.

Li C et al. (2007) Biochemical alterations in the retinas of very low-density lipoprotein receptor knockout mice: an animal model of retinal angiomatous proliferation.

[^]
85.

Thompson CL et al. (2007) Genetics of pigment changes and geographic atrophy.

[^]
86.

Lotery A et al. (2007) Progress in defining the molecular biology of age related macular degeneration.

[^]
87.

Kleinman ME et al. (2008) Sequence- and target-independent angiogenesis suppression by siRNA via TLR3.

[^]
88.

Yang Z et al. (2008) Toll-like receptor 3 and geographic atrophy in age-related macular degeneration.

[^]
89.

Fujihara M et al. (2009) A human apoB100 transgenic mouse expresses human apoB100 in the RPE and develops features of early AMD.

[^]
90.

Edwards AO et al. (2009) Geographic atrophy in age-related macular degeneration and TLR3.

[^]
91.

Allikmets R et al. (2009) Geographic atrophy in age-related macular degeneration and TLR3.

[^]
92.

Takeda A et al. (2009) CCR3 is a target for age-related macular degeneration diagnosis and therapy.

[^]
93.

Kondo N et al. (2010) Additional evidence to support the role of a common variant near the complement factor I gene in susceptibility to age-related macular degeneration.

[^]
94.

Kaneko H et al. (2011) DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration.

[^]
95.

Arakawa S et al. (2011) Genome-wide association study identifies two susceptibility loci for exudative age-related macular degeneration in the Japanese population.

[^]
96.

Fowler BJ et al. (2014) Nucleoside reverse transcriptase inhibitors possess intrinsic anti-inflammatory activity.

[^]
97.

Meyers SM et al. (1988) Monozygotic twins with age-related macular degeneration.

[^]
98.

OMIM.ORG article

Omim 603075 [^]
Update: April 29, 2019